David Kliman
- Hematology top 10%
- Hematopoietic Stem Cell Transplantation 11
- Acute Myeloid Leukemia Research 4
-
- Cancer survivorship and care 4
-
- Cytomegalovirus and herpesvirus research 4
-
- Acute Lymphoblastic Leukemia research 6
-
- Childhood Cancer Survivors' Quality of Life 5
-
- Chronic Lymphocytic Leukemia Research 4
-
- Chemotherapy-induced cardiotoxicity and mitigation 4
- Co-authors
- David GottliebEmily BlythLeighton ClancyBarbara WithersKenneth MicklethwaiteDavid BishopMing‐Celine DubosqJane Burgess
- Cited by
- HematologyTransplantationOncology
In The Last Decade
David Kliman
26 papers receiving 251 citations
Peers
Comparison fields: 5 of 48
- Hematology 71
- Transplantation 14
- Oncology 119
- Epidemiology 117
- Immunology 46
Countries citing papers authored by David Kliman
This map shows the geographic impact of David Kliman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Kliman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Kliman more than expected).
Fields of papers citing papers by David Kliman
This network shows the impact of papers produced by David Kliman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Kliman. The network helps show where David Kliman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David Kliman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 3 | |
| 8 | 2022 | 3 | |
| 9 | 2022 | 4 | |
| 10 | 2022 | 5 | |
| 11 | 2022 | 3 | |
| 12 | 2021 | 31 | |
| 13 | 2020 | 3 | |
| 14 | 2020 | 2 | |
| 15 | 2020 | 12 | |
| 16 | 2018 | 36 | |
| 17 | 2016 | 3 | |
| 18 | 2016 | 1 | |
| 19 | 2014 | 1 | |
| 20 | 2009 | 4 |
About David Kliman
David Kliman is a scholar working on Hematology, Genetics, Pediatrics, Perinatology and Child Health, Oncology and Complementary and alternative medicine, having authored 28 papers that have together received 255 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (11 papers), Acute Lymphoblastic Leukemia research (6 papers), Childhood Cancer Survivors' Quality of Life (5 papers), Acute Myeloid Leukemia Research (4 papers), Chronic Lymphocytic Leukemia Research (4 papers), Cancer survivorship and care (4 papers), Chemotherapy-induced cardiotoxicity and mitigation (4 papers) and Cytomegalovirus and herpesvirus research (4 papers). The work is most often cited by research in Hematology (71 citations), Transplantation (14 citations), Oncology (119 citations), Epidemiology (117 citations) and Immunology (46 citations). David Kliman has collaborated with scholars based in Australia, Canada and China. Frequent co-authors include David Gottlieb, Emily Blyth, Leighton Clancy, Barbara Withers, Kenneth Micklethwaite, David Bishop, Ming‐Celine Dubosq, Jane Burgess, Peter J. Shaw and Agnes S. M. Yong. Their work appears in journals such as Blood, Bone Marrow Transplantation, Biology of Blood and Marrow Transplantation, Journal of Clinical Oncology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.